An update on epidermal growth factor receptor inhibitors.
about
EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment.Chronopharmacology and mechanism of antitumor effect of erlotinib in Lewis tumor-bearing miceEpidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapyEpidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors.Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis.
P2860
An update on epidermal growth factor receptor inhibitors.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
An update on epidermal growth factor receptor inhibitors.
@ast
An update on epidermal growth factor receptor inhibitors.
@en
An update on epidermal growth factor receptor inhibitors.
@nl
type
label
An update on epidermal growth factor receptor inhibitors.
@ast
An update on epidermal growth factor receptor inhibitors.
@en
An update on epidermal growth factor receptor inhibitors.
@nl
prefLabel
An update on epidermal growth factor receptor inhibitors.
@ast
An update on epidermal growth factor receptor inhibitors.
@en
An update on epidermal growth factor receptor inhibitors.
@nl
P1476
An update on epidermal growth factor receptor inhibitors.
@en
P2093
Andrew D Seidman
P2860
P2888
P356
10.1007/S11912-002-0047-6
P50
P577
2002-01-01T00:00:00Z
P6179
1043776961